To investigate the functional role of exosomal miR-181a in AKT activation, we utilized a miR-181a inhibitor and found that the promoting effect of TEMo-Exo on AKT activation was partially abrogated when MDA-MB-231 BC cells were transfected with miR-181a inhibitor. This evidence concerns the gene AKT1 and breast cancer.